S.M. Dursun

445 total citations
12 papers, 292 citations indexed

About

S.M. Dursun is a scholar working on Psychiatry and Mental health, Pharmacology and Clinical Psychology. According to data from OpenAlex, S.M. Dursun has authored 12 papers receiving a total of 292 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Psychiatry and Mental health, 3 papers in Pharmacology and 3 papers in Clinical Psychology. Recurrent topics in S.M. Dursun's work include Schizophrenia research and treatment (4 papers), Obsessive-Compulsive Spectrum Disorders (3 papers) and Tryptophan and brain disorders (2 papers). S.M. Dursun is often cited by papers focused on Schizophrenia research and treatment (4 papers), Obsessive-Compulsive Spectrum Disorders (3 papers) and Tryptophan and brain disorders (2 papers). S.M. Dursun collaborates with scholars based in United Kingdom, Canada and Türkiye. S.M. Dursun's co-authors include M.A. Reveley, Stan Kutcher, Sheila L. Handley, Eileen M. Denovan‐Wright, H.A. Robertson, Gillian Farrar, John A. Corbett, Hugh Rickards, Tim Betts and J.G. Burke and has published in prestigious journals such as Psychological Medicine, Journal of Psychopharmacology and European Neuropsychopharmacology.

In The Last Decade

S.M. Dursun

11 papers receiving 272 citations

Peers

S.M. Dursun
R.D. Jewart United States
Stephen E. Ericksen United States
Joseph R. Magliozzi United States
Mark D. Beale United States
Tayfun Turan Türkiye
S.M. Dursun
Citations per year, relative to S.M. Dursun S.M. Dursun (= 1×) peers J Weissenburger

Countries citing papers authored by S.M. Dursun

Since Specialization
Citations

This map shows the geographic impact of S.M. Dursun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S.M. Dursun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S.M. Dursun more than expected).

Fields of papers citing papers by S.M. Dursun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S.M. Dursun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S.M. Dursun. The network helps show where S.M. Dursun may publish in the future.

Co-authorship network of co-authors of S.M. Dursun

This figure shows the co-authorship network connecting the top 25 collaborators of S.M. Dursun. A scholar is included among the top collaborators of S.M. Dursun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S.M. Dursun. S.M. Dursun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Dursun, S.M. & Süleyman Eken. (2024). Multimodal Sentiment Analysis in Natural Disaster Data on Social Media. Kocaeli Üniversitesi - AVESİS. 7(4).
2.
Chaves, Cristiano, Antônio Waldo Zuardi, Nusrat Husain, et al.. (2009). Short-Term Improvement by Minocycline Added to Olanzapine Antipsychotic Treatment in Paranoid Schizophrenia. 10 indexed citations
3.
Zuardi, Antônio Waldo, J.A.S. Crippa, Jaime E. C. Hallak, et al.. (2008). P.3.c.023 Cannabidiol for the treatment of psychosis in Parkinson's disease. European Neuropsychopharmacology. 18. S417–S418. 1 indexed citations
4.
Denovan‐Wright, Eileen M., et al.. (2002). Maintained improvement with minocycline of a patient with advanced Huntington's disease. Journal of Psychopharmacology. 16(4). 393–394. 21 indexed citations
5.
Dursun, S.M., et al.. (2001). Double-blind, placebo-controlled, cross-over trial of clozapine plus glycine in refractory schizophrenia: Negative results. European Neuropsychopharmacology. 11. S268–S268. 3 indexed citations
6.
Dursun, S.M., et al.. (2000). An exploratory approach to the serotonin syndrome: an update of clinical phenomenology and revised diagnostic criteria. Medical Hypotheses. 55(3). 218–224. 145 indexed citations
7.
Dursun, S.M., et al.. (1999). Cyproterone acetate treatment of Tourette's syndrome.. PubMed. 44(7). 710–1. 8 indexed citations
8.
Dursun, S.M., et al.. (1999). The effects of clozapine on levels of total cholesterol and related lipids in serum of patients with schizophrenia: a prospective study.. PubMed. 24(5). 453–5. 43 indexed citations
9.
Burke, J.G., S.M. Dursun, & M.A. Reveley. (1999). Refractory symptomatic schizophrenia resulting from frontal lobe lesion: response to clozapine.. PubMed. 24(5). 456–61. 8 indexed citations
10.
Rickards, Hugh, S.M. Dursun, Gillian Farrar, et al.. (1996). Increased plasma kynurenine and its relationship to neopterin and tryptophan in Tourette's syndrome. Psychological Medicine. 26(4). 857–862. 20 indexed citations
11.
Handley, Sheila L. & S.M. Dursun. (1992). Serotonin and Tourettes syndrome Movements such as head-shakes and wet-dog shakes may model human tics. 235–253. 25 indexed citations
12.
Dursun, S.M., et al.. (1982). Response of the central respiratory control mechanisms to hyperoxia and hypoxia.. PubMed. 18(3). 439–47. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026